Proteini kreatini steroidi

The company Olimp Laboratories sp. z. o. o. was founded in 1990. The company's mission rests on the idea to ensure customers a more comfortable life, health and vitality. The overriding priorities of the activity and inspiration for further development are the highest quality of products and, above all, customer satisfaction.

Over the 20 years of the foundation we have become a company of European range reaching a high position on the demanding German, Austrian, Swiss, French and Scandinavian markets. This would not have been possible without the continuous development of our own scientific database with a modern production and laboratory base. Constant cooperation with the biggest authorities and scientific and research units is led at home and abroad. Investing and merits-related activities have been undertaken by the company in order to achieve the status of pharmaceutical company and to expand the production by our own medicinal products.

Furthermore, keratin expression is helpful in determining epithelial origin in anaplastic cancers. Tumors that express keratin include carcinomas , thymomas , sarcomas and trophoblastic neoplasms . Furthermore, the precise expression pattern of keratin subtypes allows prediction of the origin of the primary tumor when assessing metastases. For example, hepatocellular carcinomas typically expresse K8 and K18, and cholangiocarcinomas express K7, K8 and K18, while metastases of colorectal carcinomas express K20, but not K7. [25]

Proteini kreatini steroidi

proteini kreatini steroidi


proteini kreatini steroidiproteini kreatini steroidiproteini kreatini steroidiproteini kreatini steroidiproteini kreatini steroidi